SCHEMBL9280712

SCHEMBL9280712

CCCCCc1ccccc1NC1CCN(C)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.46
▸ LIPG Q9Y5X9 1/20 0.45
▸ EHMT2 Q96KQ7 1/20 0.41
▸ EHMT1 Q9H9B1 1/20 0.41
▸ CYP2D6 P10635 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ NSD2 O96028 1/20 0.41
▸ POLB P06746 1/20 0.40
▸ ROCK2 O75116 1/20 0.39
▸ ROCK1 Q13464 1/20 0.39
▸ NR1H2 P55055 1/20 0.39
▸ NR1H3 Q13133 1/20 0.39
▸ BRD4 O60885 2/20 0.38
▸ BRD9 Q9H8M2 1/20 0.38
▸ SPHK1 Q9NYA1 2/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ SSTR1 P30872 1/20 0.38
▸ SSTR4 P31391 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6401914 0.88 LIPG (0.49) LIPGNR1H2NR1H3SPHK1
SCHEMBL7532688 0.84 KDM4E (0.49) LIPG
SCHEMBL2675807 0.76 CYP3A4 (0.43) CYP3A4NSD2POLBKCNH2SSTR1
SCHEMBL24260215 0.75 CYP3A4 (0.46) CYP3A4ALDH1A1NSD2POLBSSTR1
SCHEMBL24260305 0.75 CYP3A4 (0.43) CYP3A4ALDH1A1NSD2POLBSSTR1
SCHEMBL14785526 0.73 LIPG (0.56) LIPGNR1H2NR1H3KCNH2
SCHEMBL1567827 0.73 LIPG (0.56) LIPGNR1H2NR1H3KCNH2
SCHEMBL9418574 0.73 LIPG (0.56) LIPGNR1H2NR1H3KCNH2
SCHEMBL31139998 0.73 LIPG (0.56) LIPGNR1H2NR1H3KCNH2
SCHEMBL29785474 0.73 LIPG (0.56) LIPGNR1H2NR1H3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5393761-A Treatment of nervous system disorders H. LUNDBECK A/S (DK) 1995-02-28 — — US disclosed
EP-0470039-B1 Novel 3-arylindole and 3-arylindazole derivatives LUNDBECK & CO AS H (DK) 1994-12-07 — — EP disclosed
EP-0470039-A2 Novel 3-arylindole and 3-arylindazole derivatives H. LUNDBECK A/S (DK) 1992-02-05 — — EP disclosed
Send feedback